Doctor Nadia Bouabdallaoui

Montreal Heart Institute, Montreal (Canada)

Follow

Contributor content

Impact of time-to-treatment initiation of colchicine on cardiovascular outcomes after myocardial infarction: insights from the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Presentation

Impact of time-to-treatment initiation of colchicine on cardiovascular outcomes after myocardial infarction: insights from the Colchicine Cardiovascular Outcomes Trial (COLCOT)

ESC 365 is supported by

novartis

Explore sponsored resources